The therapeutic, made by AstraZeneca, is a monoclonal antibody treatment called Evusheld that is given to patients as a prophylaxis, unlike other similar treatments that infuse people with antibodies after they are diagnosed with COVID. Evusheld is not a treatment for COVID-19, and is not approved for patients diagnosed with the virus. But people such as Linna, who have previously recovered, have been prescribed it.
Treatment aimed at preventing COVID-19 for those at high risk now available at some Illinois hospitals
Prepare Now Before its too Late
Discover where products are available & compare prices
